Live Breaking News & Updates on Marc Frahm Cowen

Stay updated with breaking news from Marc frahm cowen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Incyte Corporation (INCY) Q3 2021 Earnings Call Transcript

INCY earnings call for the period ending September 30, 2021. ....

United States , Robert Andrew William Blair , Cory Kasimov , Herve Hoppenot , Eli Lilly , Salveen Richter Goldman Sachs , Kripa Devarakonda , Marc Frahm Cowen , Jay Olson Oppenheimer , Andrew Berens , Brian Abrahams , Salveen Richter , Jay Olson , Christine Cho , Marc Frahm , Kripa Devarakonda Truist , Rob Andrew , Michael Schmidt Guggenheim , Brian Abrams , Stevenh Stein , Matt Phipps , Tazeen Ahmad , Michael Schmidt , William Blair , European Academy Of Dermatology , Syndax Pharmaceuticals ,

Theravance Biopharma Inc (TBPH) Q1 2021 Earnings Call Transcript

Theravance Biopharma Inc (TBPH) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Theravance Biopharma Inc (NASDAQ: TBPH)
Popular Searches
Operator
Ladies and gentlemen, good afternoon. I d like to welcome everyone to the Theravance Biopharma First Quarter 2021 Conference Call. [Operator Instructions] [Operator Instructions]
And now, I would like to turn the call over to Gail Cohen, Vice President Corporate Communications. Please go ahead.SPONSORED:
10 stocks we like better than Theravance Biopharma
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, ....

New York , United States , Rick Winningham , Viatris Theravance Biopharma , Douglas Tsao , Anupam Rama Jpmorgan , Anupam Rama , Chin Lee , Genentech Lilly , Marc Frahm Cowen , Andrew Hindman , Vikram Purohit , Liisa Bayko , Richarda Graham , Marc Frahm , Gail Cohen , Erick Graham , Brian Skorney , Liisa Bayko Evercore , Ricke Winningham , Theravance Biopharma , Geoffrey Porges , Tazeen Ahmad , Frank Pasqualone , Andrewa Hindman , Vikram Purohit Morgan Stanley ,

Incyte Corp (INCY) Q1 2021 Earnings Call Transcript

Incyte Corp (INCY) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Incyte Corp (NASDAQ: INCY)
Operator
Hello and welcome to the Incyte s First Quarter Earnings Call. [Operator Instructions] It s now my pleasure to turn the call over to Christine Chiou. Please go ahead.SPONSORED:
10 stocks we like better than Incyte
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,
Motley Fool Stock Advisor, has tripled the market.
David and Tom just revealed what they believe are the ten best stocks for investors to buy right now. and Incyte wasn t one of them! That s right they think these 10 stocks are even better buys. ....

United States , Cory Kasimov , Herve Hoppenot , Srikripa Devarakonda , Salveen Richter Goldman Sachs , Marc Frahm Cowen , Alethia Young , Jay Olson Oppenheimer , Alethia Young Cantor Fitzgerald , Vikram Purohit , Andrew Berens , Brian Abrahams , Salveen Richter , Christiana Stamoulis , Jay Olson , Marc Frahm , Matthew Phipps William Blair , Karen Benjamin , Michael Schmidt Guggenheim , Srikripa Devarakonda Truist , Reni Benjamin , Matt Phipps , Christine Chiou , Tazeen Ahmad , Michael Schmidt , Vikram Purohit Morgan Stanley ,

Constellation Pharmaceuticals (CNST) Q4 2020 Earnings Call Transcript

Operator
Ladies and gentlemen, thank you for standing by and welcome to the Constellation Pharmaceuticals Fourth Quarter 2020 Earnings Conference Call. [Operator Instructions]
I would now like to hand the conference to your speaker today, Kia Khaleghpour, Vice President of Investor Relations and Communications. Please go ahead, ma am.
Kia Khalaghpour
Thank you, operator.
Welcome to this conference call to discuss Constellation s fourth quarter 2020 financial results and operational performance.
Please turn to slide 2. Before we begin, I want to point out that our presentation today will include forward-looking statements, which are subject to certain risks and uncertainties. Actual results may differ materially due to various important factors, including those described in the Risk Factors section as well as discussions of potential risk, uncertainty and other important factors in the Company s most recent filings with the Securities and Exchange Commis ....

United States , Marc Frahm , Jeffrey Humphrey , Patrick Trojer , Anupam Rama Jpmorgan , Anupam Rama , Brendan Delaney , Jigar Raythatha , Gemma Reeve , Marc Frahm Cowen , Jeff Humphrey , Kia Khaleghpour , Exchange Commission , Constellation Pharmaceuticals , Company Analyst , Constellation Pharmaceutical Fourth Quarter , Vice President , Investor Relations , Risk Factors , Chief Executive , Chief Commercial Officer , Chief Medical Officer , Chief Scientific Officer , Chief Financial Officer , North America , ஒன்றுபட்டது மாநிலங்களில் ,